More in detail: continuous infusion of these agents for up to two days can significantly increase GH pulsatile secretion by six to tenfold, along with increases in IGF-1, IGFBP-3, and ALS levels. The gene discussed is GH1; the disease is amyotrophic lateral sclerosis.